Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors

Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors

Bibliographic Details
Main Authors: N. Lopina, I. Dmytrenko, D. Lopin, D. Hamov, I. Dyagil
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920301668

Similar Items

Similar Items